SOLIGENIX, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SOLIGENIX, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $5.53M, a 913.23% increase year-over-year.
- SOLIGENIX, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $509.28K, a 81.12% decline year-over-year.
- SOLIGENIX, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $545.63K.
- SOLIGENIX, INC. stock issued during period, value, new issues for the quarter ending 2025-03-31 was $2.70M.
- SOLIGENIX, INC. stock issued during period, value, new issues for fiscal 2025 was $4.67M, a 335.48% increase from fiscal 2024.
- SOLIGENIX, INC. stock issued during period, value, new issues for fiscal 2024 was $1.07M.
- SOLIGENIX, INC. stock issued during period, value, new issues for fiscal 2020 was -$580.46K.
- SOLIGENIX, INC. stock issued during period, value, new issues for fiscal 2019 was -$152.52K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $5.53M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $509.28K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $4.67M 10-K · filed 2026-03-31 | |
| 2025-06-30 | $545.63K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $2.70M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $1.07M 10-K · filed 2026-03-31 | |
| 2023-06-30 | $93.01K 10-Q · filed 2024-08-09 | |
| 2023-03-31 | -$2.34K 10-Q · filed 2024-05-10 | |
| 2021-09-30 | $2.93M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $94.72K 10-Q · filed 2021-08-13 | |
| 2020-12-31 | -$13.27M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$580.46K 10-K · filed 2021-03-30 |
| 2020-09-30 | $3.23M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $5.47M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $78.34K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$152.52K 10-K · filed 2021-03-30 | |
| 2018-09-30 | $8.64M 10-Q · filed 2019-11-12 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $3.00M 10-K · filed 2018-03-15 |
| 2015-12-31 | $556.07K derived: 10-Q 12 month − 10-Q 9 month · filed 2016-05-12 | $2.00M 10-Q · filed 2016-05-12 |
| 2015-09-30 | $330.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | |
| 2015-06-30 | $354.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | |
| 2015-03-31 | $758.65K 10-Q · filed 2015-05-14 | |
| 2013-12-31 | $235.97K 10-K · filed 2015-03-25 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $253.61K 10-K · filed 2013-02-26 |
| 2011-09-30 | $184.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | |
| 2010-12-31 | $76.85K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |